$151.73
2.04% day before yesterday
NYSE, Apr 11, 10:13 pm CET
ISIN
US4781601046
Symbol
JNJ

Johnson & Johnson Stock price

$151.73
-14.13 8.52% 1M
-9.73 6.03% 6M
+7.11 4.92% YTD
+2.94 1.98% 1Y
-28.11 15.63% 3Y
+11.96 8.56% 5Y
+51.18 50.90% 10Y
NYSE, Closing price Fri, Apr 11 2025
+3.04 2.04%
ISIN
US4781601046
Symbol
JNJ
Sector
Industry

Key metrics

Market capitalization $365.65b
Enterprise Value $378.96b
P/E (TTM) P/E ratio 26.17
EV/FCF (TTM) EV/FCF 19.10
EV/Sales (TTM) EV/Sales 4.27
P/S ratio (TTM) P/S ratio 4.12
P/B ratio (TTM) P/B ratio 5.11
Dividend yield 3.24%
Last dividend (FY24) $4.91
Revenue growth (TTM) Revenue growth -4.51%
Revenue (TTM) Revenue $88.82b
EBIT (operating result TTM) EBIT $20.89b
Free Cash Flow (TTM) Free Cash Flow $19.84b
Cash position $24.52b
EPS (TTM) EPS $5.80
P/E forward 16.42
P/S forward 4.05
EV/Sales forward 4.20
Short interest 1.03%
Show more

Create a Free Account to create an Johnson & Johnson alert.

Set up alerts on Stock Price, Dividend Yield, Valuation (e.g. P/E or EV/Sales) or Strategy Scores and sit back and relax.

Johnson & Johnson Stock Analysis

Unlock Scores for Free

Analyst Opinions

24 Analysts have issued a Johnson & Johnson forecast:

11x Buy
46%
13x Hold
54%

Analyst Opinions

24 Analysts have issued a Johnson & Johnson forecast:

Buy
46%
Hold
54%

Financial data from Johnson & Johnson

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
88,819 88,819
5% 5%
100%
- Direct Costs 27,792 27,792
7% 7%
31%
61,027 61,027
3% 3%
69%
- Selling and Administrative Expenses 15,530 15,530
6% 6%
17%
- Research and Development Expense 17,265 17,265
13% 13%
19%
28,232 28,232
10% 10%
32%
- Depreciation and Amortization 7,339 7,339
2% 2%
8%
EBIT (Operating Income) EBIT 20,893 20,893
12% 12%
24%
Net Profit 14,066 14,066
1% 1%
16%

In millions USD.

Don't miss a Thing! We will send you all news about Johnson & Johnson directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Johnson & Johnson Stock News

Neutral
CNBC
one day ago
CNBC's Jim Cramer on Friday told investors which market-moving events to follow next week. He pinpointed earnings reports from major banks like Goldman Sachs, as well as Johnson & Johnson and Netflix,
Positive
Seeking Alpha
one day ago
Johnson & Johnson offers stability and limited downside risk, making it a solid investment in volatile markets, despite not being a high-growth stock. The company's fiscal 2024 results showed moderate growth in sales and earnings, with notable performance in the oncology and cardiovascular segments. Analysts expect low-to-mid single-digit growth for Johnson & Johnson, with a focus on operationa...
Negative
CNBC
one day ago
President Donald Trump's planned tariffs on pharmaceuticals imported into the U.S. could have wide-ranging consequences on the drug supply chain, manufacturers and American patients, some experts told CNBC.  The tariffs could disrupt the complex pharmaceutical supply chain, potentially driving up the prices of drugs in the U.S. and exacerbating shortages of critical medicine.
More Johnson & Johnson News

Company Profile

Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments: Consumer, Pharmaceutical, and Medical Devices. The Consumer segment includes products used in the baby care, oral care, beauty, over-the-counter pharmaceutical, women's health, and wound care markets. The Pharmaceutical segment focuses on therapeutic areas such as immunology, infectious diseases ad vaccines, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The Medical Devices segment offers products used in the orthopedic, surgery, cardiovascular, diabetes care, and eye health fields. The company was founded by Robert Wood Johnson I, James Wood Johnson and Edward Mead Johnson Sr. in 1886 and is headquartered in New Brunswick, NJ.

Head office United States
CEO Joaquin Duato
Employees 138,100
Founded 1887
Website www.jnj.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today